Chronic Suppurative Otitis Media
1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
LP
Lee's PharmaceuticalChina - Guangzhou
1 program1
Pazufloxacin Mesilate ear dropsPhase 11 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Lee's PharmaceuticalPazufloxacin Mesilate ear drops
Clinical Trials (1)
Total enrollment: 33 patients across 1 trials
Pazufloxacin Mesilate Ear Drops in Patients With Chronic Suppurative Otitis Media
Start: Jul 2018Est. completion: Jun 201933 patients
Phase 1Unknown
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space